Stay updated on High-Dose Eteplirsen in DMD Clinical Trial
Sign up to get notified when there's something new on the High-Dose Eteplirsen in DMD Clinical Trial page.

Latest updates to the High-Dose Eteplirsen in DMD Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page shows a minor revision update from v3.4.1 to v3.4.2; no substantive content changes are detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision metadata updated from v3.4.0 to v3.4.1, with no visible changes to the study page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page; no study data or eligibility details appear to be affected.SummaryDifference0.0%

- Check63 days agoChange DetectedIndividual location subsections (Alabama Locations, Florida Locations, Georgia Locations, Attica Locations, Sinaloa Locations, Pomeranian Voivodeship Locations, West Yorkshire Locations) were removed and replaced with a consolidated 'Locations' section listing those areas. The page revision tag updated from v3.3.2 to v3.3.3 and the HHS Vulnerability Disclosure entry was removed.SummaryDifference0.6%

- Check91 days agoChange DetectedRevision: v3.3.2 appears on the page, replacing v3.2.0. No changes to study details or page structure are evident; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check99 days agoChange DetectedDeleted the government funding status notice. The study's essential details and sections on the page remain unchanged.SummaryDifference0.2%

Stay in the know with updates to High-Dose Eteplirsen in DMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the High-Dose Eteplirsen in DMD Clinical Trial page.